These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 82284)

  • 21. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
    Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
    Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The mechanism of change in the bioelectric activity of the brain in tumors of the prostate gland].
    Tkachuk VN; Grodzovskaia FL; Parfent'eva LN; Portnoĭ AS
    Vopr Onkol; 1974; 20(10):29-36. PubMed ID: 4139811
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of primary transitional cell carcinoma of the prostate].
    Konya E; Nose K; Kiwamoto H; Kataoka K; Kajikawa H; Kurita T
    Hinyokika Kiyo; 1999 Jun; 45(6):439-42. PubMed ID: 10442290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of primary transitional cell carcinoma of the prostate].
    Hashimoto H; Watanabe Y; Mizunaga M; Sasaki M; Kaneko S; Tokunaka S; Yachiku S; Fujita M
    Hinyokika Kiyo; 1989 Jul; 35(7):1235-8. PubMed ID: 2678986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of a prostatic adenocarcinoma in the cysto-prostatectomy specimens of an invasive tumor of the bladder].
    Baron JC; Zerbib M; Levêque JM; Deslignières S; Boccon-Gibod L; Debré B; Steg A
    Ann Urol (Paris); 1989; 23(2):119-22. PubMed ID: 2742333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer of the prostate detected in the adenomectomy specimen].
    Revol M; Delannoy P; Faure G
    J Urol Nephrol (Paris); 1974; 80(10-11):939-41. PubMed ID: 4142050
    [No Abstract]   [Full Text] [Related]  

  • 30. The frequency of benign prostate hypertrophy in Calabar.
    Umezurike BI; Ekanem TB; Eluwa MA; Etta KK; Udo-Affah GA; Aligwekwe AU
    Niger Postgrad Med J; 2006 Sep; 13(3):236-9. PubMed ID: 17278305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate health: definitely a men's health issue.
    Porche DJ
    Am J Mens Health; 2008 Jun; 2(2):105. PubMed ID: 19477774
    [No Abstract]   [Full Text] [Related]  

  • 33. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
    J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of prostatic adenocarcinoma with transitional cell and squamous cell carcinomas of the same organ].
    Samsonov VA; Kolomoĭtsev SV
    Arkh Patol; 1983; 45(2):28-34. PubMed ID: 6847410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The current approach to the management of benign hypertrophy of the prostate].
    Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O
    Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nursing of patients with prostatic diseases. Physiopathology of prostatic hypertrophy and prostatic cancer].
    Sugita A
    Kurinikaru Sutadi; 1983 Jul; 4(7):778-84. PubMed ID: 6194386
    [No Abstract]   [Full Text] [Related]  

  • 39. [Association of 2 prostatic tumors].
    Zabala-Egurrola JA; Pertusa Peña C; del Tanago JG; Llarena Ibarguren R; Arruza Etxebarriá A; Arregui Erbina P
    Arch Esp Urol; 1989; 42(6):583-6. PubMed ID: 2817992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1767 transurethral resections.
    Türkyilmaz RK
    Turk J Pediatr; 1984; 26(1-4):103-8. PubMed ID: 6085660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.